Applications of flow cytometry to clinical microbiology.
about
Single-cell microbiology: tools, technologies, and applications.Volume and antimicrobial activity of secretions of the uropygial gland are correlated with malaria infection in house sparrowsEarly events in macrophage killing of Aspergillus fumigatus conidia: new flow cytometric viability assayNovel method using a laser scanning cytometer for detection of mycobacteria in clinical samples.Physiological response of Bacillus cereus vegetative cells to simulated food processing treatments.Current and emerging techniques for antibiotic susceptibility testsFlow cytometry compared with indirect immunofluorescence for rapid detection of dengue virus type 1 after amplification in tissue culture.Antifungal susceptibility testing: practical aspects and current challenges.Pattern recognition in flow cytometry.A photonic-microfluidic integrated device for reliable fluorescence detection and counting.Flow cytometric determination of the effects of antibacterial agents on Mycoplasma agalactiae, Mycoplasma putrefaciens, Mycoplasma capricolum subsp. capricolum, and Mycoplasma mycoides subsp. mycoides large colony typeCharacterization and bacterial anti-adherent effect on modified PMMA denture acrylic resin containing platinum nanoparticlesFluorescence in situ hybridization and sequential catalyzed reporter deposition (2C-FISH) for the flow cytometric sorting of freshwater ultramicrobacteria.Rapid microscopy and use of vital dyes: potential to determine viability of Cryptococcus neoformans in the clinical laboratory.What does the future hold for clinical microbiology?Current status and future prospects of using advanced computer-based methods to study bacterial colonial morphology.Imaging flow cytometry analysis of intracellular pathogens.Ligand engagement of Toll-like receptors regulates their expression in cortical microglia and astrocytesAntifungal susceptibility testing by flow cytometry: is it the future?Functional single-cell analyses: flow cytometry and cell sorting of microbial populations and communities.Life, death, and in-between: meanings and methods in microbiology.Applications of flow cytometry in plant pathology for genome size determination, detection and physiological status.Next-generation antimicrobial susceptibility testing.Antimycobacterial susceptibility testing methods for natural products research.Advances and applications of molecular cloning in clinical microbiology.Antibody Engineering for Pursuing a Healthier FutureA bioinspired peptide scaffold with high antibiotic activity and low in vivo toxicityRapid identification and detection of intracellular survival testing of mycobacterium smegmatis mc²155 that contains eis gene from mycobacterium tuberculosis by flow cytometry.Do different standard plate counting (IDF/ISSO or AOAC) methods interfere in the conversion of individual bacteria counts to colony forming units in raw milk?Development of a flow cytometric method to analyze subpopulations of bacteria in probiotic products and dairy startersFlow cytometric assessment of susceptibilities of Streptococcus pyogenes to erythromycin and rokitamycin.Determination of the viability of Aeromonas hydrophila in different types of water by flow cytometry, and comparison with classical methods.New approach for serological testing for leptospirosis by using detection of leptospira agglutination by flow cytometry light scatter analysis.Comparison of flow cytometric and Alamar Blue tests with the proportional method for testing susceptibility of Mycobacterium tuberculosis to rifampin and isoniazid.Antimicrobial susceptibility testing in 90 min by bacterial cell count monitoring.A combination of positive dielectrophoresis driven on-line enrichment and aptamer-fluorescent silica nanoparticle label for rapid and sensitive detection of Staphylococcus aureus.Enrichment of Yersinia pestis from blood cultures enables rapid antimicrobial susceptibility determination by flow cytometry.Improved antibiotic susceptibility test of Orientia tsutsugamushi by flow cytometry using monoclonal antibody.Efficient inactivation of Burkholderia pseudomallei or Francisella tularensis in infected cells for safe removal from biosafety level 3 containment laboratories.Assessment of Escherichia coli B with enhanced permeability to fluorochromes for flow cytometric assays of bacterial cell function.
P2860
Q24562808-1C90516C-91EF-41EF-AE5A-114B7A1C1DC4Q26315514-1128BA4F-ABF5-4F20-9886-144F5E712162Q28362985-C6EC1B29-8FBD-41C6-8D65-C2AA3336D75EQ31041644-FF336F52-9288-4F07-8881-7E6B04441C31Q33388300-CE9B6644-9460-4626-A802-0ECEB53C9B1CQ33820956-C46B2DDE-C995-4B78-9388-4BF0B40DE46AQ33973691-BD478970-FB24-428A-A1EA-3C957466A254Q33975757-449A85BA-114B-4B9F-9110-584115527743Q34295429-A77DFF44-AC4A-41EE-95FC-585436BE54FFQ34445413-3123FF74-C38C-4C34-819D-D7F0AD9A93A9Q34973674-E1FF5682-86A1-4D42-B790-761CC0C02697Q35203545-CCDB7D54-C347-462E-AAEF-BC54D3DE9A7DQ35233740-F2A2ECFF-B2CD-4441-8B72-55561485960BQ35549784-91CEB8D7-D301-404E-8CD8-AAB6107CC979Q35709176-08DE7737-66EF-4496-A639-4239C5077120Q35845773-D7F59A78-D467-4A57-BEFC-BA54DE2E8DB2Q36136833-CA9705B3-2963-40ED-811D-95A1EAC3E2EAQ36416913-DD07EB0A-7B52-4BE3-AF7C-87777B58DD36Q36511353-A1C56EB9-B04D-4C3F-AD43-338925BA6620Q37718885-CF6DEE75-1DCE-4293-A26A-AAA9A36F90C1Q37894495-291F0848-FAD6-4696-B1AA-7B58679C2FA0Q37897279-5BD5E64A-E532-4501-A36E-ADA2933340D0Q38088958-9815FDDA-77D5-4153-B9CE-FEF29C189466Q38137055-8E53ABF7-A965-4F72-BFCD-983D87CD86ACQ38229428-F74EE47C-A509-439C-8044-E92C215F8024Q38731632-6ED8DBC8-49DA-4C0A-A42E-86811F6E06A1Q39001413-BAFA5891-106D-4C8A-9C63-CB519B60CBF4Q39486521-DCF280D8-52F0-4612-A333-6287049F0C53Q39598692-BA3D6095-911B-4B0B-AF5B-B297A26FAB39Q39639861-F4A7EE35-7F32-45B8-A89E-AF5FB9A7C1F8Q39730576-21F53451-F1A4-472E-BFC6-1CA33E397B69Q40714430-DBA29744-43D7-421E-B5D5-A3F7D848AFCAQ40762595-E57F8FE6-D7D2-4C27-99ED-23CCB47A168BQ40834138-BF68364E-06D1-40E1-A962-887F86619095Q41110338-14A0059E-7C70-4D4F-8A70-8FC3ED3A2BD0Q41241077-0BDE2EAA-848D-40C8-81E6-B866D4C38C3AQ41446383-FCE925C3-956B-4EFB-9AFF-8CFEEE086C96Q42121392-A8DDC39E-12FB-41CA-AE05-EBDBAA7E5FDAQ42231992-0C2A6A7B-7197-45CD-B990-999319D0F2B8Q42526495-ACCF0E1A-016C-4BB0-96EF-B6C36E98E333
P2860
Applications of flow cytometry to clinical microbiology.
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Applications of flow cytometry to clinical microbiology.
@ast
Applications of flow cytometry to clinical microbiology.
@en
Applications of flow cytometry to clinical microbiology.
@nl
type
label
Applications of flow cytometry to clinical microbiology.
@ast
Applications of flow cytometry to clinical microbiology.
@en
Applications of flow cytometry to clinical microbiology.
@nl
prefLabel
Applications of flow cytometry to clinical microbiology.
@ast
Applications of flow cytometry to clinical microbiology.
@en
Applications of flow cytometry to clinical microbiology.
@nl
P2860
P50
P1476
Applications of flow cytometry to clinical microbiology.
@en
P2093
M Sánchez-Pérez
P2860
P304
P356
10.1128/CMR.13.2.167-195.2000
P407
P577
2000-04-01T00:00:00Z